Molecular Diagnostics Data Presented at ESCMID 2026
Faster Diagnostics for Critical Infections At ESCMID 2026, Inbiome presented new clinical data focused on how molecular diagnostics can accelerate…
Inbiome Secures $16M Investment for Diagnostics
Investment Supports Expansion of Molecular Diagnostics Dutch diagnostics company Inbiome has secured a $16 million investment round from a consortium…
Molecular Culture Improves Pleural Infection Detection
Study Evaluates Molecular Diagnostics in Pleural Fluid A newly published study evaluating Molecular Culture ID (MC-ID) in pleural fluid diagnostics…
Inbiome Appoints Gerardas Dambrauskas as EMEA Sales Director
Supporting Commercial Expansion Across EMEA Inbiome has appointed Gerardas Dambrauskas as its new EMEA Sales Director as the company enters…
Culture-Free Sepsis Diagnostics Presented at ESICM 2025
New Research Presented to ICU Specialists At ESICM 2025 in Munich, Anna Wijen of Maastricht UMC+ presented new research focused…
Molecular Diagnostics Highlighted During AMR Awareness Week
The Growing Challenge of Antimicrobial Resistance Antimicrobial resistance (AMR) continues to be a major global healthcare challenge as bacteria become…
